Skip to main content
Livermore
Livermore
ZHEN

Rapport Therapeutics, Inc.

RAPP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0002012593

In the last 90 days, Rapport Therapeutics, Inc. insiders filed 0 open-market purchases and 9 sales; 160 institutions reported holding it in 13F filings for Q2 2026, worth $2.13B in total; no superinvestor holds it.

Q1 2026 vs. Q4 2025

How the institutions holding Rapport Therapeutics, Inc. changed between Q4 2025 and Q1 2026.

All holders in Q1 2026All holders in Q4 2025

13F holders of RAPP: Q4 2025 compared with Q1 2026
MeasureQ4 2025Of which not filed for Q1 2026Q1 2026Change
Holders1443147+6
Shares51.1M1.82M52.5M+3.22M (+6.5%)
Value$1.55B$55.3M$1.64B+$146.9M (+9.8%)

3 institutions that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so the changes leave them out.

New holders (30)

Institutions that held Rapport Therapeutics, Inc. at the end of Q1 2026 but not at the end of Q4 2025.

Institutions new to RAPP in Q1 2026
InstitutionSharesValue% of portfolio
Vanguard Capital Management LLC1,325,082$41.5M0.00%
Capital World Investors536,607$16.8M0.00%
Vanguard Portfolio Management LLC320,909$10.0M0.00%
Vanguard Fiduciary Trust Co189,253$5.92M0.00%
Candriam Luxembourg S.C.A.185,925$5.82M0.03%
Freestone Grove Partners LP127,783$4.00M0.03%
Y-Intercept (Hong Kong) Ltd35,825$1.12M0.02%
Vanguard Asset Management, Ltd18,532$579.9K0.00%
Vanguard Global Advisers, LLC17,240$539.4K0.00%
VARCOV Co.15,473$484.1K0.18%
Optimize Financial Inc14,656$458.6K0.23%
Walleye Capital LLC11,148$348.8K0.00%
Soleus Capital Management, L.P.10,000$312.9K0.01%
State of New Jersey Common Pension Fund D9,773$305.8K0.00%
Clear Wave Wealth Management LLC9,500$297.3K0.08%
Verition Fund Management LLC7,531$235.6K0.00%
Vanguard Investments Australia, Ltd.7,259$227.1K0.00%
Allspring Global Investments Holdings, LLC6,868$214.9K0.00%
Mangrove Partners6,753$211.3K0.02%
State Board of Administration of Florida Retirement System6,612$206.9K0.00%
Quantbot Technologies LP6,493$203.2K0.01%
KBC Group NV962$30.0K0.00%
Zurcher Kantonalbank (Zurich Cantonalbank)513$16.1K0.00%
Caitong International Asset Management Co., Ltd197$6.16K0.00%
Versant Capital Management, Inc27$8450.00%
Rothschild Investment LLC20$6260.00%
MAI Capital Management6$1880.00%
US Bancorp5$1560.00%
Allworth Financial LP4$1260.00%
Covestor Ltd5$00.00%

Sold out (24)

Institutions that held Rapport Therapeutics, Inc. at the end of Q4 2025 and filed for Q1 2026 without it.

Institutions that sold out of RAPP in Q1 2026
InstitutionShares, Q4 2025Value, Q4 2025
EAM Investors, LLC85,555$2.60M
Eversept Partners, LP59,233$1.80M
ExodusPoint Capital Management, LP34,651$1.05M
Dark Forest Capital Management LP21,074$639.4K
Brevan Howard Capital Management LP16,783$509.2K
Silverarc Capital Management, LLC9,659$293.1K
Canada Pension Plan Investment Board9,100$276.1K
Profund Advisors LLC8,880$269.4K
Quadrature Capital Ltd8,837$268.1K
Citadel Advisors LLC8,099$245.7K
Squarepoint Ops LLC7,859$238.4K
Rafferty Asset Management, LLC7,801$236.7K
Landscape Capital Management, L.L.C.6,594$200.1K
Los Angeles Capital Management LLC6,690$179.8K
Quest Partners LLC3,754$113.9K
Meeder Asset Management Inc1,208$36.7K
Amalgamated Bank894$27.0K
SRS Capital Advisors, Inc.500$15.2K
Cygnus Capital Advisors, LLC341$10.0K
Aster Capital Management (DIFC) Ltd300$9.10K
Daiwa Securities Group Inc.121$4.00K
SageView Advisory Group, LLC16$486
Bare Financial Services, Inc16$485
Farther Finance Advisors, LLC1$30

Not filed for Q1 2026 yet (3)

Institutions that held Rapport Therapeutics, Inc. at the end of Q4 2025 and haven't filed a 13F for Q1 2026. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding RAPP in Q4 2025 that haven't filed for Q1 2026
InstitutionShares, Q4 2025Value, Q4 2025
Vanguard Group Inc1,817,757$55.2M
Sandia Investment Management LP6,000$182.0K
Global Retirement Partners, LLC40$1.21K